
pmc: PMC11092722
AbstractSolve-RD is a pan-European rare disease (RD) research program that aims to identify disease-causing genetic variants in previously undiagnosed RD families. We utilised 10-fold coverage HiFi long-read sequencing (LRS) for detecting causative structural variants (SVs), single nucleotide variants (SNVs), insertion-deletions (InDels), and short tandem repeat (STR) expansions in extensively studied RD families without clear molecular diagnoses. Our cohort includes 293 individuals from 114 genetically undiagnosed RD families selected by European Rare Disease Network (ERN) experts. Of these, 21 families were affected by so-called ‘unsolvable’ syndromes for which genetic causes remain unknown, and 93 families with at least one individual affected by a rare neurological, neuromuscular, or epilepsy disorder without genetic diagnosis despite extensive prior testing.Clinical interpretation and orthogonal validation of variants in known disease genes yielded thirteen novel genetic diagnoses due tode novoand rare inherited SNVs, InDels, SVs, and STR expansions. In an additional four families, we identified a candidate disease-causing SV affecting several genes including anMCF2/FGF13fusion andPSMA3deletion. However, no common genetic cause was identified in any of the ‘unsolvable’ syndromes. Taken together, we found (likely) disease-causing genetic variants in 13.0% of previously unsolved families and additional candidate disease-causing SVs in another 4.3% of these families.In conclusion, our results demonstrate the added value of HiFi long-read genome sequencing in undiagnosed rare diseases.
Male, Bioinformatics, genetics [Rare Diseases], Undiagnosed Diseases, Polymorphism, Single Nucleotide, Medical Biosciences - Radboud University Medical Center, 3105 Genetics, Solve-RD consortium, Rare Diseases, INDEL Mutation, Humans, Internal Medicine - Radboud University Medical Center, 11 Medical and Health Sciences, genetics [Undiagnosed Diseases], Whole Genome Sequencing, Genome, Human, Research, 06 Biological Sciences, Pedigree, diagnosis [Rare Diseases], Human Genetics - Development and lifelong plasticity, Human Genetics - Radboud University Medical Center, Female, Human medicine, methods [Whole Genome Sequencing], Solve-RD DITF-ITHACA, Solve-RD DITF-Euro-NMD, Solve-RD DITF-RND, Solve-RD DITF-EpiCARE, ddc: ddc:540
Male, Bioinformatics, genetics [Rare Diseases], Undiagnosed Diseases, Polymorphism, Single Nucleotide, Medical Biosciences - Radboud University Medical Center, 3105 Genetics, Solve-RD consortium, Rare Diseases, INDEL Mutation, Humans, Internal Medicine - Radboud University Medical Center, 11 Medical and Health Sciences, genetics [Undiagnosed Diseases], Whole Genome Sequencing, Genome, Human, Research, 06 Biological Sciences, Pedigree, diagnosis [Rare Diseases], Human Genetics - Development and lifelong plasticity, Human Genetics - Radboud University Medical Center, Female, Human medicine, methods [Whole Genome Sequencing], Solve-RD DITF-ITHACA, Solve-RD DITF-Euro-NMD, Solve-RD DITF-RND, Solve-RD DITF-EpiCARE, ddc: ddc:540
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 21 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
